Clinical Trials Directory

Trials / Completed

CompletedNCT01449149

Proton Radiation for Chordomas and Chondrosarcomas

Proton Radiation For Chordomas and Chondrosarcomas

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Abramson Cancer Center at Penn Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objectives of this study are 1) To evaluate the feasibility and acute side effects of proton therapy for chordomas and chondrosarcomas and 2) To evaluate clinical outcomes and long term side effects of proton beam radiation for treatment of chordomas and chondrosarcomas.

Detailed description

This trial will be conducted in two phases: a feasibility then a phase II trial. Once feasibility and safety are established in the first 12 pts. the phase II study will begin. Proton therapy at standard doses is not known to improve clinical outcome but will likely reduce fatigue and toxicity.

Conditions

Interventions

TypeNameDescription
RADIATIONProton Therapy

Timeline

Start date
2010-03-01
Primary completion
2025-07-01
Completion
2025-09-04
First posted
2011-10-10
Last updated
2025-12-05
Results posted
2025-12-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01449149. Inclusion in this directory is not an endorsement.

Proton Radiation for Chordomas and Chondrosarcomas (NCT01449149) · Clinical Trials Directory